Discover how BPMN enhances transparency and efficiency in the pharmaceutical industry, leading to faster drug approvals and safer medications, with insights from industry experts and recent findings.
Published on: 2022-10-18 09:32:38
A new blog post of MI Nautics was published on Oct 18, 2022 with the original title:
Warum sich die Pharmaindustrie mit BPMN beschäftigen sollte
Overview:
This article discusses the importance of Business Process Model and Notation (BPMN) for the pharmaceutical industry. It highlights how BPMN aids in automating, visualizing, and ensuring compliance in drug development processes, ultimately leading to faster market approvals and safer medicines.
Core content:
- The pharmaceutical industry should adopt BPMN for effective process automation, better visualization, and enhanced traceability, as no single notation serves all these functions adequately.
- Industry 4.0 concepts and Data Integrity by Design are essential for maintaining product specifications and accelerating drug approval while ensuring safety.
- Central orchestration and integration of all laboratory and business processes enhance transparency and control across pharmaceutical development.
Learnings:
- Readers will learn how standardized notations like BPMN contribute to making pharmaceutical processes transparent, measurable, and automated, facilitating regulatory compliance.
- The content provides insights into how adopting BPMN can lead to a more streamlined drug development process, reducing risks while implementing sustainable practices.
- Understanding the role of BPMN in ensuring data integrity and regulatory acceptance can benefit professionals aiming to enhance operational efficiency in the pharmaceutical sector.
The original content was published in German.
